Clinical Trials Directory

Trials / Completed

CompletedNCT05177978

The Cognitive Effects of 6- and 12-weeks Administration of a Food Supplement Containing Phosphatidylserine in Healthy Children Aged 8 to 12 Years

The Chronic Cognitive Effects of 6- and 12-weeks Administration of a Food Supplement Containing Phosphatidylserine: A Double Blind, Randomized, Placebo Controlled, Parallel Groups Study in Healthy Children Aged 8 to 12 Years

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
208 (actual)
Sponsor
Northumbria University · Academic / Other
Sex
All
Age
8 Years – 12 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to assess the cognitive effects (attention, learning, and memory) of 6 and 12 weeks administration of a supplement containing phosphatidylserine in comparison to a placebo in healthy children aged 8 to 12 years old. The study will utilize Rey Auditory Verbal Learning Test (RAVLT) and Computerised Mental Performance Assessment System (COMPASS, Northumbria University) for a broad assessment of cognitive function/learning, and actigraphy to monitor sleep.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTPhosphatidylserinePhosphatidylserine containing supplement (2 x chewable gummies/day; Total daily dose of 100 mg elemental phosphatidylserine)
DIETARY_SUPPLEMENTPlaceboPlacebo comparator (2 x chewable gummies/day, matched to shape and color without active ingredient)

Timeline

Start date
2020-11-02
Primary completion
2022-08-14
Completion
2022-08-14
First posted
2022-01-05
Last updated
2022-09-28

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT05177978. Inclusion in this directory is not an endorsement.